跳至主要内容
临床试验/NCT02080130
NCT02080130撤回不适用

Efficacy of Two Probiotic Preparations in Children With Acute Viral Diarrhoea, Randomised Controlled Trial

Sinaloa Pediatric Hospital2 个研究点 分布在 1 个国家开始时间: 2014年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
2
主要终点
Duration of diarrhoea in hours

研究概览

简要总结

The purpose of this study is to determine which of two different preparations of probiotics is effective in the treatment of acute viral diarrhoea in children.

详细描述

Children and infants, aged 1 month to 5 years, with acute diarrhoea, will be randomised to receive either saccharomyces boulardii, a combination probiotic (Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus rhamnosus, Lactobacillus plantarum, Bifidobacterium infantis, Streptococcus thermophillus) or placebo, to determine if one shortens the duration of diarrhoea.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
1 Month 至 5 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of acute viral gastroenteritis

排除标准

  • Moderate or severe dehydration
  • Malnutrition
  • Immunodeficiencies
  • Sepsis or bacterial infection
  • Previous use of antibiotics, antidiarrheal drugs, or probiotics, in the last four weeks.
  • Hospitalisation
  • No phone number
  • Illiteracy

研究组 & 干预措施

Probiotics combination

Experimental

LACTIPAN®. Probiotics combination sachet. One sachet orally, BID, for 5 days. Lactobacillus acidophilus............. 1.00 x 109 cfu Lactobacillus casei........................ 1.00 x 109 cfu Lactobacillus rhamnosus............. 4.40 x 108 cfu Lactobacillus plantarum............... 1.76 x 108 cfu Bifidobacterium infantis................ 2.76 x 107 cfu Streptococcus thermophillus....... 6.66 x 105 cfu

干预措施: Probiotics combination (Dietary Supplement)

Placebo

Placebo Comparator

Placebo sachet. One sachet orally, BID, for 5 days.

干预措施: Placebo (Other)

Saccharomyces boulardii

Experimental

FLORATIL®. Saccharomyces boulardii 200 mg sachet. One sachet orally, BID, for 5 days.

干预措施: Saccharomyces boulardii (Dietary Supplement)

结局指标

主要结局

Duration of diarrhoea in hours

时间窗: Up to 7 days

次要结局

  • Percentage of children requiring hospitalisation(Up to 7 days)
  • Adverse effects(Up to 7 days)
  • Number of liquid stools(Up to seven days)

研究者

发起方
Sinaloa Pediatric Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Giordano Perez Gaxiola

Pediatrician

Sinaloa Pediatric Hospital

研究点 (2)

Loading locations...

相似试验